According to a newly published market research report by 24LifeSciences, the global 3D bioprinting for life science R&D market was valued at USD 1.2 billion in 2024 and is projected to reach USD 3.8 billion by 2031, growing at a compound annual growth rate (CAGR) of 18.7% during the forecast period 2025-2031.
3D bioprinting is an innovative manufacturing technique that enables precise...
Cell culture technology plays a fundamental role in modern biotechnology, enabling scientists to study cellular behavior, develop new drugs, and advance regenerative medicine. By growing cells in controlled laboratory environments, researchers can better understand disease mechanisms, evaluate therapeutic effectiveness, and accelerate drug discovery processes. The evolution from traditional 2D...
Executive Summary Immune-Modulating Oncology Biologic Drugs Market Size and Share: Global Industry Snapshot
CAGR Value
The global immune-modulating oncology biologic drugs market size was valued at USD 10.10 billion in 2025 and is expected to reach USD 28.54 billion by 2033, at a CAGR of13.87% during the forecast period
The research and analysis...
The traditional pharmaceutical landscape is undergoing a radical transformation. For decades, bringing a new drug to market was a marathon often taking over ten years and costing upwards of $2.6 billion, with a failure rate that would make most venture capitalists shudder. Enter Silicon Valley’s favorite protagonist: Artificial Intelligence.
The market was valued at USD 4.46 billion...
According to a newly published market research report by 24LifeSciences, global cell lysis market was valued at USD 2.81 billion in 2024 and is projected to reach USD 5.07 billion by 2031, growing at a compound annual growth rate (CAGR) of 9.0% during the forecast period 2025-2031.
Cell lysis, a fundamental process involving the breaking down of cell membranes to release intracellular...
English
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek